Cancer Death Rate Decline Doubling, Annual Report To The Nation Finds
Main Category: Cancer / OncologyAlso Included In: Smoking / Quit Smoking
Article Date: 17 Oct 2007 - 1:00 PDT
A new report from the nation's leading cancer organizations shows cancer death rates decreased on average 2.1 percent per year from 2002 through 2004, nearly twice the annual decrease of 1.1 percent per year from 1993 through 2002. The findings are in the "Annual Report to the Nation on the Status of Cancer, 1975-2004, Featuring Cancer in American Indians and Alaska Natives" published online October 15, 2007 and appearing in the November 15, 2007, issue of Cancer.
A featured special section provides the most comprehensive cancer data to date for American Indians and Alaska Natives (AI/AN) across the United States. Cancer incidence rates among AI/AN men and women varied two-fold among six geographic regions of the country. From 1999 through 2004, AI/AN men from the Northern Plains region and AI/AN women from Alaska and the Northern and Southern Plains regions had higher cancer incidence rates than non-Hispanic white (NHW) men and women in the same areas.
Among the general population, the report shows that long-term declines in cancer death rates continued through 2004 for both sexes and, despite overall higher death rates for men, the declines from 2002 through 2004 were 2.6 percent per year among men and 1.8 percent per year among women. Death rates decreased for the majority of the top 15 cancers in men and women. Important declines were noted for the three leading causes of cancer deaths in men: lung, prostate and colorectal cancers. In women, deaths rates from colorectal cancer and breast cancer decreased, while the rate of increase for lung cancer deaths slowed substantially.
"The significant decline in cancer death rates demonstrates important progress in the fight against cancer that has been achieved through effective tobacco control, screening, early detection, and appropriate treatment," said Centers for Disease Control and Prevention (CDC) Director, Julie L. Gerberding, M.D. "As a nation, we must commit to continuing and enhancing these important public health efforts."
"The evidence is unmistakable: we are truly turning the tide in the cancer battle," said John R. Seffrin, Ph.D., chief executive officer of the American Cancer Society (ACS). "The gains could be even greater if everyone in the U.S. had access to essential healthcare, including primary care and prevention services."
Overall cancer incidence rates (the rates at which new cancers are diagnosed) for both sexes and all races combined declined slightly from 1992 through 2004. Incidence rates for female breast cancer dropped substantially from 2001 through 2004. This drop is possibly related to declining use of hormone replacement therapy as well as the recently reported decline in use of screening mammography. Also, lung cancer incidence rates in women stabilized from 1998 through 2004 after long term increases, and in men the rate declined 1.8 percent per year from the period 1991 through 2004. Colorectal cancer incidence rates decreased by more than 2.0 percent per year for men and women, likely due to prevention through the removal of precancerous polyps.
* For all cancers combined, AI/AN incidence rates were lower in the Southwest and higher in the Plains and Alaska
* Lung and colorectal cancer incidence rates were highest in the Northern Plains and Alaska and were significantly elevated in comparison with NHW rates
* The incidence rates for cancers of the kidney, stomach, liver, cervix and gallbladder were higher in AI/AN than in NHW populations in all regions combined
* With the exception of Alaska, AI/AN persons were less likely than NHW persons to be diagnosed with early stages of colorectal cancer, with the difference being larger in the Southwest, Northern Plains, and Southern Plains than other regions
* AI/AN women in all regions of the U.S. were less likely than NHW women to be diagnosed with localized breast cancer.
"We are firmly committed to addressing cancer health disparities so that the benefits of decades of research can reach all Americans," said National Cancer Institute (NCI) Director John E. Niederhuber, M.D. "The fact that lung and colorectal cancers rates were higher in some American Indian and Alaska Native populations points to the work we still have to do."
AI/AN populations were more likely to live in poverty and less likely to have a high school education and health coverage when compared to NHW persons, all indicators of less access to cancer prevention and control services. Also, current smoking rates were high among AI/AN overall, with the highest prevalence among AI/AN in Alaska and in the Northern Plains; in all regions, more AI/AN than NHW persons reported being obese; and screening rates for breast, colorectal, prostate and cervical cancers were lower among AI/AN than NHW persons.
"We now have an infrastructure in this country for obtaining high-quality information about new cases of cancer and we can now describe the successes in cancer interventions and treatment as well as uncover populations with varying risks and outcomes," said Holly L. Howe, Ph.D., executive director of North American Association of Central Cancer Registries (NAACCR). "Without this surveillance, we would be ill-equipped to address the challenges we face in further reducing the cancer burden."
The authors report that earlier detection of disease through screening, improved prognosis through more effective treatment, tobacco control, and reduction in inequalities in cancer care all point to the success of the nation's dedication and focus on reducing the burden of cancer in the U.S. The study was conducted by scientists at the CDC, ACS, NCI, which is part of the National Institutes of Health, and NAACCR, in collaboration with scientists from the Indian Health Service and Mayo Clinic College of Medicine.
###
Espey DK, Wu X, Swan J, Wiggins C, Jim M, Ward E, Wingo PA, Howe HL, Ries LAG, Miller BA, Jemal A, Ahmed F, Cobb N, Kaur JS, Edwards BK. Annual Report to the Nation on the Status of Cancer, 1975-2004, Featuring Cancer in American Indians and Alaska Natives. Cancer; Published online, October 15, 2007 (DOI: 10.1002/cncr. 23044); Print issue date, November 15, 2007.
For more information on this report, visit the following Web sites:
Click here to view the full report
Click here for a Q&A on this Report
Click here for Spanish translations of this press release and a Q&A
ACS: http://www.cancer.org/
CDC's Division of Cancer Prevention and Control: http://www.cdc.gov/cancer
IHS: http://www.ihs.gov/
NAACCR: http://www.naaccr.org/
NCI: http://www.cancer.gov/
SEER Homepage: http://www.seer.cancer.gov/
Source: NCI Office of Media Relations
NIH/National Cancer Institute
Visit our cancer / oncology section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/85763.php>
APA
http://www.medicalnewstoday.com/releases/85763.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (2)
Cancer Death Rates Continue To Fall?
posted by Gregory D. Pawelski on 29 Oct 2007 at 4:35 pmThe paucity of tangible progress with regard to overall cancer mortality may be explained by the well-known phenomenon of "lead bias" (diagnosing earlier in the course of disease), which may account for why a lot of earlier diagnoses provide misleadingly improved statistics, which are not really related either to treatment or to diagnosis.
Prostate cancer is the best example of this. Breast cancer may be another example. It is clear that women who are diagnosed with advanced lesions do poorly and people who are diagnosed with small lesions do better. Tumor stage is always associated with survival and usually with long term survival and curability.
Many men with prostate cancer will never have symptoms or illness from their disease. Prostate cancer is an unpredictable, stochastic, evolutionary process. It is unknowable if early-stage prostate cancer will progress and cause clinical disease in a given patient. Many men happily coexist with prostate cancer and die of something else, like old age.
I would want to see results of a prospective, randomized trial showing actual survival advantages (as well as a comparison of the cost in terms of treatment associated morbidity) before being subjected to a PSA test and the possibility of then getting directed to biopsies and then getting directed to a radical prostatectomy without any clear indication that this is an advantage.
I am a believer in the efficacy of some types of screening procedures, like colonoscopies. Many adenomatous polyps have been found and removed during this procedure. By not having those polyps removed, it is very likely that one would have developed colon cancer along the way.
There have been truly minuscule improvements as a result of adjuvant chemotherapy and the net benefit to the community of breast cancer patients in the real world isn't all that clear. The criticism remains: All of the clinical trials resources have gone toward driving a square peg (one-size-fits-all chemotherapy) into a round hole (notoriously heterogeneous disease).
In academic centers, the patients are entered into clinical trials of square peg in round hole therapy. In the private sector, patients are treated with drugs which generate the most revenue for the treating oncologists, overtreat with infusion chemotherapy, and encourage the patient to receive 2nd, 3rd, and 4th line chemotherapy, regardless of the likelihood of meaningful benefit.
Improvements in overall survival for all patients are owing largely to a marked trend for earlier dignosis and surgical technique. Even this doesn't mean all that many more patients are being cured. If you diagnose someone earlier in the course of disease, of course they'll live long from the time of diagnosis.
Good News In The Fight Against Cancer!
posted by weighfirst on 30 Oct 2007 at 12:52 pmThere's actually very good news on the cancer front!
And, it's all about prevention, (where we should be putting a ton of money.)
Access to care truly is the message. When people have equal access to care, they have equal outcomes.
If everyone stopped smoking, had mammograms, and had colonsocopies, the number of cancer cases would drop dramatically.
It's really very simple and the good news is more and more people, as indicated in this good news story, are doing it.
Ovarian cancer, breast cancer? it's dropping big time with women decling HRT.
Prevention is the key.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





